(S (NP-SBJ (NN Transcription) (NN factor) (NN jun-B)) (VP (VBZ is) (NP-PRD (NP (NN target)) (PP (IN of) (NP (NP (JJ autoreactive) (NNS T-cells)) (PP (IN in) (NP (NN IDDM))))))) (. .))
(S (NP-SBJ (NP (NN Target) (NNS antigens)) (VP (VBN defined) (NP (-NONE- *)) (PP (IN by) (NP (NP (NNS autoantibodies)) (PP (IN in) (NP (NN IDDM))))))) (VP (VBP include) (NP-COOD (NP (NN insulin)) (, ,) (NP (NP (DT a) (JJ putative) (NN glycolipid)) (SBAR (WHNP-41 (WDT that)) (S (NP-SBJ (-NONE- *T*-41)) (VP (VBZ reacts) (PP (IN with) (NP (NN islet) (NN cell) (NNS antibodies))))))) (, ,) (CC and) (NP (NP (DT a) (JJ 64,000-M-LRB-r-RRB-) (NN protein)) (VP (ADVP-TMP (RB recently)) (VBN identified) (NP (-NONE- *)) (PP (IN as) (NP (JJ glutamic) (NN acid) (NN decarboxylase))))))) (. .))
(S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ (NP (DT some) (NN IDDM) (NN sera)) (SBAR (WHNP-42 (WDT that)) (S (NP-SBJ (-NONE- *T*-42)) (VP (VBP contain) (NP (NP (NNS antibodies)) (PP (TO to) (NP (JJ glutamic) (NN acid) (NN decarboxylase)))))))) (ADVP (RB also)) (VP (VBP coprecipitate) (NP (NP (DT a) (JJ 38,000-M-LRB-r-RRB-) (NN protein)) (PP (IN from) (NP (NNS islets))))) (. .))
(S (NP-SBJ (DT This) (NN study)) (VP-COOD (VP (VBD used) (NP-43 (DT a) (JJ high) (NN titer) (JJ anti-38,000-M-LRB-r-RRB-) (NN serum)) (S (NP-SBJ (-NONE- *-43)) (VP (TO to) (VP (VB screen) (NP (NN bacteriophage) (NN lambda) (NN cDNA) (NN expression) (NNS libraries)))))) (CC and) (VP (VBD identified) (NP (NP-COOD (NP (JJ human) (NN islet)) (CC and) (NP (JJ placental) (NNS clones))) (VP (VBG encoding) (NP (NP (NP (NN jun-B)) (, ,) (NP (DT the) (JJ nuclear) (NN transcription) (NN protein)) (, ,)) (PP (IN of) (NP (VBN predicted) (CD 38,000) (NN M-LRB-r-RRB-)))))))) (. .))
(S (NP-SBJ (JJ Peripheral) (NN blood) (NNS T-cells)) (VP (VBD exhibited) (NP (JJ significant) (NN proliferation)) (PP (IN in) (NN response) (TO to) (NP (NP (DT a) (JJ recombinant) (NN fragment)) (PP (IN of) (NP (NP (NP (NN jun-B)) (PRN (-LRB- -LRB-) (NP (NN amino) (NNS acids) (CD 1-180)) (-RRB- -RRB-))) (PP (IN in) (NP-COOD (NP (QP (QP (CD 12) (IN of) (CD 17)) (PRN (-LRB- -LRB-) (NP (CD 71) (NN %)) (-RRB- -RRB-))) (JJ recent-onset) (NN IDDM) (NNS subjects)) (, ,) (NP (NP (QP (QP (CD 8) (IN of) (CD 16)) (PRN (-LRB- -LRB-) (NP (CD 50) (NN %)) (-RRB- -RRB-))) (JJ ICA-positive) (JJ first-degree) (NNS relatives)) (PP (IN of) (NP (NP (NN IDDM) (NNS subjects)) (SBAR (WHNP-44 (WP who)) (S (NP-SBJ (-NONE- *T*-44)) (VP (VBD were) (PP-PRD (IN at) (NP (NN risk))))))))) (, ,) (NP (QP (QP (CD 3) (IN of) (CD 12)) (PRN (-LRB- -LRB-) (NP (CD 25) (NN %)) (-RRB- -RRB-))) (JJ other) (JJ autoimmune) (NN disease) (NNS subjects)) (, ,) (CC and) (NP (QP (CD 0) (IN of) (CD 10)) (JJ healthy) (NN control) (NNS subjects))))))))) (. .))
(S (NP-SBJ (NP (NN Proliferation)) (PP (TO to) (NP (NN tetanus) (NN toxoid)))) (VP (VBD did) (RB not) (VP (VB differ) (ADVP (RB significantly)) (PP (IN between) (NP (DT the) (NNS groups))))) (. .))
(S (NP-SBJ (NP (NNS Responses)) (PP (TO to) (NP (NN jun-B)))) (VP (VBD were) (RB not) (ADJP-PRD (JJ related) (PP (TO to) (NP-COOD (NP (NN age)) (, ,) (NP (NN sex)) (, ,) (CC or) (NP (JJ human) (NN leukocyte) (NN antigen) (NN status)))))) (. .))
(S (ADVP (RB Thus)) (, ,) (NP-SBJ-45 (JJ autoreactive) (NNS T-cells)) (VP-COOD (VP (VBP identify) (NP (NP (NP (DT a) (JJ novel) (NN antigen)) (, ,) (NP (NN p38) (NN jun-B)) (, ,)) (PP (IN in) (NP (NN IDDM))))) (CC and) (VP (VBP appear) (S (NP-SBJ (-NONE- *-45)) (VP (TO to) (VP (VB indicate) (NP (NP (NNS subjects)) (PP (IN at) (NP (NP (NN risk)) (PP (IN for) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ clinical) (NN disease))))))))))))) (. .))
